Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2

. 1996 ; 44 (1) : 27-35.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid08613140

The inbred strain STS/A exhibits a higher proliferative response in the mixed lymphocyte culture (MLC) to stimulator cells of all 11 tested inbred mouse strains with 10 different major histocompatibility complex (MHC) haplotypes, as well as to stimulation with IL-2 than does the strain BALB/cHeA. However, alloantigen-stimulated BALB/c cells produce more IL-2 than STS/A cells. To study the genetic basis of these differences, we used 20 recombinant congenic strains (RCS) of the CcS/Dem series. Each of these CcS/Dem RC strains contains a different subset of about 12.5% of genes from the STS/A strain and the remaining approximately 87.5% of BALB/c origin genes. As a result the multiple non-linked genes responsible for phenotypic differences between BALB/c and STS/A became separated into different CcS/Dem strains. The strain distribution pattern (SD) of high or low MLC response of individual CcS/Dem strains to stimulator cells of four different strains was almost identical, indicating that differences in responsiveness, rather than the alloantigenic difference itself, determine the magnitude of the response, and that the responsiveness to different alloantigens is largely controlled by the same genes. The SDP of IL-2 stimulation was different from that of MLC responsiveness. The differences in the proliferative responses observed among individual CcS/Dem strains were not due to differences in numbers of CD3+, CD4+ or CD8+ cells or to the observed differences in IL-2 production, and hence they likely reflect genetically determined intrinsic properties of T cells. These results show that a set of non-linked genes controls proliferative responses in MLC irrespective of the MHC haplotype of the stimulator cells, and that stimulation with IL-2 and production of IL-2 are controlled by different subsets of genes. Since the genomes of all RCS are extensively characterized by microsatellite markers, they can be used to map the genes controlling proliferative responsiveness to stimulation with alloantigens and IL-2.

Zobrazit více v PubMed

Immunogenetics. 1988;28(6):455-8 PubMed

J Immunol. 1978 Jun;120(6):2027-32 PubMed

J Exp Med. 1988 Aug 1;168(2):795-800 PubMed

Mamm Genome. 1991;1(4):217-27 PubMed

Immunogenetics. 1995;41(5):301-11 PubMed

Nature. 1985 May 23-29;315(6017):333-6 PubMed

Int Immunol. 1992 Dec;4(12):1389-97 PubMed

J Immunol. 1990 Nov 1;145(9):2938-45 PubMed

J Immunol. 1988 Nov 1;141(9):2907-11 PubMed

Transplantation. 1992 Dec;54(6):1071-8 PubMed

Genomics. 1995 Feb 10;25(3):609-14 PubMed

Transplantation. 1993 May;55(5):1159-66 PubMed

Transplantation. 1994 Jun 15;57(11):1638-42 PubMed

Immunogenetics. 1986;24(6):416-22 PubMed

J Immunol. 1988 Feb 15;140(4):1148-52 PubMed

Cell. 1993 Apr 9;73(1):5-8 PubMed

Immunol Rev. 1983;74:29-56 PubMed

Transplant Rev. 1972;12:91-140 PubMed

Nature. 1985 Mar 7-13;314(6006):98-100 PubMed

Immunogenetics. 1980;10(6):545-55 PubMed

Mamm Genome. 1994 Mar;5(3):174-6 PubMed

Oncogene. 1992 Mar;7(3):563-6 PubMed

Eur J Immunol. 1973 Oct;3(10):645-9 PubMed

J Immunol. 1987 Jun 15;138(12):4175-9 PubMed

J Immunol. 1986 Apr 1;136(7):2348-57 PubMed

Cell. 1989 May 19;57(4):521-4 PubMed

Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844-8 PubMed

Biomedicine. 1973 Sep;18(5):401-7 PubMed

Eur J Immunol. 1979 Nov;9(11):875-86 PubMed

Lab Anim. 1988 Jan;22(1):61-6 PubMed

FASEB J. 1992 Jul;6(10):2826-35 PubMed

Science. 1970 Jun 5;168(3936):1170-9 PubMed

Genomics. 1995 Dec 10;30(3):553-7 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...